These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 28410617)

  • 1. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
    Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.
    Jacobo-Cejudo MG; Valdés-Ramos R; Guadarrama-López AL; Pardo-Morales RV; Martínez-Carrillo BE; Harbige LS
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
    Poreba M; Rostoff P; Siniarski A; Mostowik M; Golebiowska-Wiatrak R; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2018 Feb; 17(1):29. PubMed ID: 29452596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial.
    Bozbas E; Zhou R; Soyama S; Allen-Redpath K; Mitchell JL; Fisk HL; Calder PC; Jones C; Gibbins JM; Fischer R; Hester S; Yaqoob P
    Am J Clin Nutr; 2024 May; 119(5):1175-1186. PubMed ID: 38484976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
    Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH
    Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Double-Blinded, Placebo-Controlled Trial Investigating the Effect of Fish Oil Supplementation on Gene Expression Related to Insulin Action, Blood Lipids, and Inflammation in Gestational Diabetes Mellitus-Fish Oil Supplementation and Gestational Diabetes.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Taghizadeh M; Asemi Z
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease.
    Harving F; Svensson M; Flyvbjerg A; Schmidt EB; Jørgensen KA; Eriksen HH; Christensen JH
    Clin Nephrol; 2015 May; 83(5):279-85. PubMed ID: 25816805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of marine-derived omega-3 fatty acid supplementation effects on leptin, adiponectin, and the leptin-to-adiponectin ratio.
    Rausch J; Gillespie S; Orchard T; Tan A; McDaniel JC
    Nutr Res; 2021 Jan; 85():135-152. PubMed ID: 33482602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro.
    Koutsaliaris IK; Pantazi D; Tsouka AN; Argyropoulou O; Tellis CC; Tselepis AD
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
    Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
    Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease.
    Mackay I; Ford I; Thies F; Fielding S; Bachoo P; Brittenden J
    Atherosclerosis; 2012 Apr; 221(2):514-20. PubMed ID: 22296885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prenatal EPA and DHA on maternal and cord blood insulin sensitivity: a secondary analysis of the mothers, omega 3, and mental health study.
    England JA; Jain J; Holbrook BD; Schrader R; Qualls C; Mozurkewich E
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):452. PubMed ID: 31783739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans.
    Nelson GJ; Schmidt PS; Bartolini GL; Kelley DS; Kyle D
    Lipids; 1997 Nov; 32(11):1129-36. PubMed ID: 9397397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus.
    Stirban A; Nandrean S; Götting C; Stratmann B; Tschoepe D
    Horm Metab Res; 2014 Jun; 46(7):490-2. PubMed ID: 24356795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women.
    Phang M; Lincz LF; Garg ML
    J Nutr; 2013 Apr; 143(4):457-63. PubMed ID: 23390192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnicity, plasma phospholipid fatty acid composition and inflammatory/endothelial activation biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Steffen BT; Steffen LM; Tracy R; Siscovick D; Jacobs D; Liu K; He K; Hanson NQ; Nettleton JA; Tsai MY
    Eur J Clin Nutr; 2012 May; 66(5):600-5. PubMed ID: 22215136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation.
    Larson MK; Tormoen GW; Weaver LJ; Luepke KJ; Patel IA; Hjelmen CE; Ensz NM; McComas LS; McCarty OJ
    Am J Physiol Cell Physiol; 2013 Feb; 304(3):C273-9. PubMed ID: 23174566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.